Full Name
Andrew Michael Lindsay Lever
(not current staff)
Variants
Andrew M L Lever
 
Main Affiliation
 
 
Email
mdcamll@nus.edu.sg
 

Publications

Refined By:
Author:  Lever, A.M
File Format:  Adobe PDF
Subject:  Humans

Results 1-20 of 29 (Search time: 0.023 seconds).

Issue DateTitleAuthor(s)
120082008 Nobel prize in Medicine for discoverers of HIVLever, A.M.L ; Berkhout, B
22017A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoirFun, A; Mok, H.P; Wills, M.R; Lever, A.M 
32006A method to estimate the efficiency of gene expression from an integrated retroviral vectorMok, H.P; Lever, A 
42018A new method for detecting signal regions in ordered sequences of real numbers, and application to viral genomic dataGog J.R.; Lever A.M.L. ; Skittrall J.P.
52015A novel combined RNA-protein interaction analysis distinguishes HIV-1 Gag protein binding sites from structural change in the viral RNA leaderKenyon, J.C ; Prestwood, L.J; Lever, A.M.L 
62018An RNA-binding compound that stabilizes the HIV-1 gRNA packaging signal structure and specifically blocks HIV-1 RNA encapsidationIngemarsdotter, C.K; Zeng, J; Long, Z; Lever, A.M.L ; Kenyon, J.C 
72005Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interactionGrainger, D.J; Lever, A.M.L 
82014Current perspectives on RNA secondary structure probingKenyon, J ; Prestwood, L; Lever, A 
92007Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivityL'Hernault, A; Greatorex, J.S; Crowther, R.A; Lever, A.M.L 
102015Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) productionMeng, B; Ip, N.C.Y; Prestwood, L.J; Abbink, T.E.M; Lever, A.M.L 
112016HIV and Zika: When will we be able to end these epidemics?Wainberg, M.A; Lever, A.M.L 
122012HIV-2 genome dimerization is required for the correct processing of gag: A second-site reversion in matrix can restore both processes in dimerization-impaired mutant virusesL'Hernault, A; Weiss, E.U; Greatorex, J.S; Lever, A.M 
132014How will the ebola crisis impact the HIV epidemic?Wainberg, M.A; Lever, A.M 
142015Identification of RNA helicases in human immunodeficiency virus 1 (HIV-1) replication – A targeted small interfering RNA library screen using pseudotyped and WT HIV-1Williams, C.A; Abbink, T.E.M; Jeang, K.-T; Lever, A.M.L 
152005Identification of unique reciprocal and non reciprocal cross packaging relationships between HIV-1, HIV-2 and SIV reveals an efficient SIV/HIV-2 lentiviral vector system with highly favourable features for in vivo testing and clinical usageStrappe, P.M; Hampton, D.W; Bown, D; Gonzalez, B.-C; Caldwell, M; Fawcett, J.W; Lever, A.M.L 
162013Immune adaptor ADAP in T cells regulates HIV-1 transcription and cell-cell viral spread via different co-receptorsWei, B; Han, L; Abbink, T.E.M; Groppelli, E; Lim, D; Thaker, Y.R; Gao, W; Zhai, R; Wang, J; Lever, A ; Jolly, C; Wang, H; Rudd, C.E
172013Inhibition of rotavirus replication by downregulation of fatty acid synthesisGaunt, E.R; Cheung, W; Richards, J.E; Lever, A ; Desselberger, U
182017Innovations in the quantitative virus outgrowth assay and its use in clinical trialsNorton, N.J; Fun, A; Bandara, M; Wills, M.R; Mok, H.P; Lever, A.M.L 
192013Lipidome analysis of rotavirus-infected cells confirms the close interaction of lipid droplets with viroplasmsGaunt, E.R; Zhang, Q; Cheung, W; Wakelam, M.J.O; Lever, A.M.L ; Desselberger, U
202013Monsef Benkirane awarded 2013 Ming K. Jeang Foundation Retrovirology Prize: Landmark HIV-1 research honouredBerkhout, B; Lever, A ; Wainberg, M; Fassati, A; Borrow, P; Fujii, M